Banco Davivienda S.A.

SNSE:DAVIVIENCL Stock Report

Market Cap: CL$2.1t

Banco Davivienda Valuation

Is DAVIVIENCL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DAVIVIENCL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DAVIVIENCL (CLP4380) is trading above our estimate of fair value (CLP3199.07)

Significantly Below Fair Value: DAVIVIENCL is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for DAVIVIENCL?

Key metric: As DAVIVIENCL is an unprofitable bank we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for DAVIVIENCL. This is calculated by dividing DAVIVIENCL's market cap by their current book value.
What is DAVIVIENCL's PB Ratio?
PB Ratio0.6x
BookCol$15.48t
Market CapCol$9.27t

Price to Book Ratio vs Peers

How does DAVIVIENCL's PB Ratio compare to its peers?

The above table shows the PB ratio for DAVIVIENCL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average1.1x
ITAUCL Banco Itaú Chile
0.6x7.9%CL$2.2t
SCOTIABKCL Scotiabank Chile
0.8xn/aCL$2.8t
SECURITY Grupo Security
1xn/aCL$1.1t
BSANTANDER Banco Santander-Chile
2.1x9.3%CL$8.8t
DAVIVIENCL Banco Davivienda
0.6x105.7%CL$9.3t

Price-To-Book vs Peers: DAVIVIENCL is good value based on its Price-To-Book Ratio (0.6x) compared to the peer average (1.1x).


Price to Book Ratio vs Industry

How does DAVIVIENCL's PB Ratio compare vs other companies in the South American Banks Industry?

1 CompanyPrice / BookEstimated GrowthMarket Cap
DAVIVIENCL 0.6xIndustry Avg. 1.1xNo. of Companies11PB00.61.21.82.43+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: DAVIVIENCL is good value based on its Price-To-Book Ratio (0.6x) compared to the South American Banks industry average (1.1x).


Price to Book Ratio vs Fair Ratio

What is DAVIVIENCL's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DAVIVIENCL PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.6x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate DAVIVIENCL's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DAVIVIENCL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCL$4,380.00
CL$4,655.66
+6.3%
4.9%CL$5,084.53CL$4,421.33n/a5
Nov ’25CL$4,380.00
CL$4,398.20
+0.4%
8.0%CL$4,939.39CL$3,844.13n/a5
Oct ’25CL$4,380.00
CL$4,398.20
+0.4%
8.0%CL$4,939.39CL$3,844.13n/a5
Sep ’25CL$4,380.00
CL$5,137.95
+17.3%
13.8%CL$6,196.22CL$4,107.87n/a7
Aug ’25CL$4,380.00
CL$5,137.95
+17.3%
13.8%CL$6,196.22CL$4,107.87n/a7
Jul ’25CL$4,380.00
CL$5,333.91
+21.8%
13.3%CL$6,340.11CL$4,203.26n/a8
Jun ’25CL$4,380.00
CL$5,333.91
+21.8%
13.3%CL$6,340.11CL$4,203.26n/a8
May ’25CL$4,380.00
CL$5,548.16
+26.7%
13.3%CL$6,594.77CL$4,372.09n/a8
Apr ’25CL$4,380.00
CL$5,626.35
+28.5%
13.5%CL$6,724.72CL$4,458.24n/a8
Mar ’25CL$4,380.00
CL$5,626.35
+28.5%
13.5%CL$6,724.72CL$4,458.24n/a8
Feb ’25CL$4,380.00
CL$5,226.18
+19.3%
11.4%CL$6,219.30CL$4,489.61n/a7
Jan ’25CL$3,682.60
CL$4,872.25
+32.3%
14.0%CL$5,760.90CL$3,939.83n/a7
Dec ’24CL$3,682.60
CL$4,863.23
+32.1%
13.6%CL$5,713.57CL$3,907.45n/a7
Nov ’24CL$3,682.60
CL$5,470.61
+48.6%
16.8%CL$6,883.60CL$3,996.93CL$4,380.006
Oct ’24CL$3,780.00
CL$5,238.73
+38.6%
14.9%CL$6,522.11CL$4,418.21CL$4,380.005
Sep ’24CL$4,097.90
CL$5,238.73
+27.8%
14.9%CL$6,522.11CL$4,418.21CL$4,380.005
Aug ’24CL$4,917.60
CL$5,360.86
+9.0%
14.6%CL$6,495.89CL$4,400.44CL$4,380.006
Jul ’24CL$4,917.60
CL$4,949.27
+0.6%
15.0%CL$5,969.94CL$4,044.15CL$4,380.005
Jun ’24CL$4,917.60
CL$4,850.89
-1.4%
19.9%CL$6,506.94CL$3,693.13CL$4,380.006
May ’24CL$4,917.60
CL$5,443.50
+10.7%
13.3%CL$6,661.84CL$4,591.27CL$4,380.006
Apr ’24CL$4,917.60
CL$5,368.11
+9.2%
11.0%CL$6,312.08CL$4,418.46CL$4,380.006
Mar ’24CL$4,917.60
CL$5,368.11
+9.2%
11.0%CL$6,312.08CL$4,418.46CL$4,380.006
Feb ’24CL$4,917.60
CL$5,681.97
+15.5%
10.5%CL$6,631.95CL$4,642.37CL$4,380.006
Jan ’24CL$6,122.30
CL$5,681.97
-7.2%
10.5%CL$6,631.95CL$4,642.37CL$3,682.606
Dec ’23CL$6,122.30
CL$6,179.74
+0.9%
12.3%CL$7,144.93CL$4,869.84CL$3,682.606
Nov ’23CL$6,122.30
CL$6,848.16
+11.9%
14.1%CL$8,225.72CL$5,133.65CL$3,682.606

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies